NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: Clinical Operations WCN B.V.
Conditions: Atherosclerotic Cardiovascular Disease, STEMI, Non STEMI
Countries: Netherlands
Guideline recommended evidence-based clinical care correlates with improved patient outcomes. In real life care, however, adherence to guideline recommendations remains suboptimal. In real life, patients may receive suboptimal treatment and as a result treatment targets are not always met. To support and improve secondary prevention for cardiovascular disease, PENELOPE and PENELOPE-CTRL are designed to support guideline implementation on lipid management and provide valuable feedback to care-givers on real world data.
Sex: ALL
Age: 18 Years to 70 Years
Healthy volunteers: No
Study type: OBSERVATIONAL
Inclusion Criteria: * Age \>18 and ≤70 years * Alive at hospital discharge after admission for (N)STEMI between 1-1-2019 and 31-08-2020 * Planned for follow-up at a participating PENELOPE CTRL site * History of T2DM and/or history of ASCVD defined as either one of: * cerebrovascular disease/ event: transient ischemic attack, cerebral infarction, amaurosis fugax, retinal infarction * Coronary artery disease/ event: unstable angina pectoris, MI, ACS, coronary revascularization (coronary angioplasty or surgical procedure for coronary bypass) * Peripheral artery disease (symptomatic and documented obstruction of a distal extremity artery or surgical intervention (percutaneous transluminal angioplasty, bypass or amputation) Exclusion Criteria: * Pregnant and lactating women * Participation in lipid modifying drug trials up to two years after index cardiovascular event
- Alkmaar, Netherlands
- Delft, Netherlands
- Deventer, Netherlands
- Emmen, Netherlands
- Hardenberg, Netherlands
- Helmond, Netherlands
- Leiden, Netherlands
- Meppel, Netherlands
- Nijmegen, Netherlands
- The Hague, Netherlands
- The Hague, Netherlands
- Utrecht, Netherlands
- Veldhoven, Netherlands